The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

Journal of Hypertension

Volumn 24, Issue 8, 2006, Pages 1589-1597

  Rodríguez, Amaia ^a   Frühbeck, Gema ^a   Gómez Ambrosi, Javier ^a   Catalán, Victoria ^a   Sáinz, Neira ^a   Díez, Javier ^b,c   Zalba, Guillermo ^b   Fortuño, Ana ^b,d  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Centre for Applied Medical Research   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Angiotensin; Calcium; Hypertension; Leptin; Obesity; Smooth muscle

Indexed keywords

ANGIOTENSIN II; CALCIUM; FURA 2; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FLUORESCENCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WESTERN BLOTTING;

EID: 33746733607     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000239295.17636.6e     Document Type: Article

References (46)

1. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 1998; 97:2099-2100.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-1428.
3. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk. Arch Internal Med 2002; 162:1867-1872.
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395:763-769.
5. Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 2003; 42:488-493.
6. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100:270-278.
7. Frühbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999; 48:903-908.
8. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003; 26:147-152.
9. Nakagawa K, Higashi Y, Sasaki S, Oshima T, Matsuura H, Chayama K. Leptin causes vasodilation in humans. Hypertens Res 2002; 25:161-165.
10. Lembo G, Vecchione C, Fratta L, Marruno G, Trimarco V, d'Amati G, Trimarco B. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49:293-297.
11. Kimura K, Tsuda K, Baba A, Kawabe T, Boh-oka S, Ibata M, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 2000; 273:745-749.
12. Fortuño A, Rodríguez A, Gómez-Ambrosi J, Muñiz P, Salvador J, Díez J, Frühbeck G. Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in rat aorta. Endocrinology 2002; 143:3555-3560.
13. Wold LE, Relling DP, Duan J, Norby FL, Ren J. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension. Role of JAK/STAT pathway. Hypertension 2002; 39:69-74.
14. Umeda M, Kanda T, Murakami H. Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertens Res 2003; 26:485-492.
15. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10:1171-1174.
16. Henriksen JH, Holst JJ, Moller S, Andersen UB, Bendtsen F, Jensen G. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci 2000; 99:527-534.
17. Gálvez-Prieto B, Abderrahim F, Fernández-Alfonso MS. Influence of perivascular adipose tissue and leptin on mesenteric vascular resistance in hypertension [abstract]. J Hypertens 2004; 22:S335.
18. Villarreal D, Reams G, Freeman RH. Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats. Kidney Int 2000; 58:989-994.
19. Fortuño A, Muñiz P, Ravassa S, Rodríguez JA, Fortuño MA, Zalba G, Diez J. Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension 1999; 34:138-143.
20. Gómez-Ambrosi J, Catalán V, Díez-Caballero A, Martínez-Cruz LA, Gil MJ, García-Foncillas J, et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004; 18:215-217.
21. PE Applied Biosystems. Relative quantitation of Gene Expression. User bulletin #2. Foster City, CA: The PerkinElmer Corporation; 1997.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1982; 260:3440-3450.
23. Gendron G, Gobeil F Jr, Morin J, D'Orleans-Juste P, Regoli D. Contractile responses of aortae from WKY and SHR to vasoconstrictors. Clin Exp Hypertens 2004; 26:511-523.
24. Samain E, Pili-Floury S, Bouillier H, Clichet A, Safar M, Dagher G, et al. Effect of propofol on vasoconstriction and calcium mobilization induced by Angiotensin II differs in aortas from normotensive and hypertensive rats. Clin Exp Pharmacol Physiol 2004; 31:163-168.
25. Arendshorst WJ, Chatziantoniou C, Daniels FH. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int 1990; 30 (Suppl):S92-S96.
26. Pravenec M, Zidek V, Landa V, Simakova M, Mlejnek P, Kazdova L, et al. Genetic analysis of 'metabolic syndrome' in the spontaneously hypertensive rat. Physiol Res 2004; 53 (Suppl 1):S15-S22.
27. Caro JF, Sinha MK, Kolaczynski JW, Zhang YPL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45:1455-1462.
28. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005; 54:2012-2018.
29. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181:1-10.
30. Franks PW, Brage S, Luan J, Ekelund U, Rahman M, Farooqi IS, et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obesity Res 2005; 13:1476-1484.
31. Touyz RM, Schiffrin EL. Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats. J Hypertens 1997; 15:1431-1439.
32. Zalba G, San José G, Moreno MU, Fortuño MA, Fortuño A, Beaumont FJ, Díez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38:1395-1399.
33. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51:168-173.
34. Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO Hypertension 2000; 36:501-505.
35. Glavaski-Joksimovic A, Rowe EW, Jeftinija K, Scanes CG, Anderson LL, Jeftinija S. Effects of leptin on intracellular calcium concentrations in isolated porcine somatotropes. Neuroendocrinology 2004; 80:73-82.
36. Corsonello A, Perticone F, Malara A, De Domenico D, Loddo S, Buemi M, et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 2003; 27:566-573.
37. Glaum SR, Hara M, Bindokas VP, Lee CC, Polonsky KS, Bell GI, Miller RJ. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996; 50:230-235.
38. Ookuma M, Ookuma K, York DA. Effects of leptin on insulin secretion from isolated rat pancreatic islets. Diabetes 1998; 47:219-223.
39. Eiras S, Camiña JP, Díaz-Rodríguez E, Gualillo O, Casanueva FF. Leptin inhibits lysophosphatidic acid-induced intracellular calcium rise by a protein kinase C-dependent mechanism. J Cell Physiol 2004; 201:214-226.
40. Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, Ricordi C, Habener JF. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999; 84:670-676.
41. Tabet F, Savoia C, Schiffrin EL, Touyz RM. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 2004; 44:200-208.
42. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47:141-150.
43. Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S, Karmazyn M. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1 dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Ther 2005; 315:1075-1084.
44. Lin ZH, Fukuda N, Jin XQ, Yao EH, Ueno T, Endo M, et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 2004; 44:42-47.
45. Hosoi T, Okuma Y, Ono A, Nomura Y. Alteration of leptin-induced STAT3 activation in the brain of senescence-accelerated mouse (SAM) P8. Biol Pharm Bull 2005; 28:1514-1516.
46. Barton M, Carmona R, Ortmann J, Krieger JE, Traupe T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol 2003; 35:826-837.